IBDEI0SN ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14115,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,14116,0)
 ;;=205.10^^85^876^38
 ;;^UTILITY(U,$J,358.3,14116,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14116,1,4,0)
 ;;=4^CML w/o Remission
 ;;^UTILITY(U,$J,358.3,14116,1,5,0)
 ;;=5^205.10
 ;;^UTILITY(U,$J,358.3,14116,2)
 ;;=^336856
 ;;^UTILITY(U,$J,358.3,14117,0)
 ;;=205.11^^85^876^37
 ;;^UTILITY(U,$J,358.3,14117,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14117,1,4,0)
 ;;=4^CML in Remission
 ;;^UTILITY(U,$J,358.3,14117,1,5,0)
 ;;=5^205.11
 ;;^UTILITY(U,$J,358.3,14117,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,14118,0)
 ;;=232.9^^85^876^30
 ;;^UTILITY(U,$J,358.3,14118,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14118,1,4,0)
 ;;=4^CA Skin in Situ (Bowen's)
 ;;^UTILITY(U,$J,358.3,14118,1,5,0)
 ;;=5^232.9
 ;;^UTILITY(U,$J,358.3,14118,2)
 ;;=^267724
 ;;^UTILITY(U,$J,358.3,14119,0)
 ;;=233.0^^85^876^13
 ;;^UTILITY(U,$J,358.3,14119,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14119,1,4,0)
 ;;=4^CA Breast in Situ
 ;;^UTILITY(U,$J,358.3,14119,1,5,0)
 ;;=5^233.0
 ;;^UTILITY(U,$J,358.3,14119,2)
 ;;=^267735
 ;;^UTILITY(U,$J,358.3,14120,0)
 ;;=233.1^^85^876^14
 ;;^UTILITY(U,$J,358.3,14120,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14120,1,4,0)
 ;;=4^CA Cervical in Situ
 ;;^UTILITY(U,$J,358.3,14120,1,5,0)
 ;;=5^233.1
 ;;^UTILITY(U,$J,358.3,14120,2)
 ;;=^267736
 ;;^UTILITY(U,$J,358.3,14121,0)
 ;;=233.7^^85^876^10
 ;;^UTILITY(U,$J,358.3,14121,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14121,1,4,0)
 ;;=4^CA Bladder in Situ
 ;;^UTILITY(U,$J,358.3,14121,1,5,0)
 ;;=5^233.7
 ;;^UTILITY(U,$J,358.3,14121,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,14122,0)
 ;;=238.4^^85^876^50
 ;;^UTILITY(U,$J,358.3,14122,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14122,1,4,0)
 ;;=4^Polycytheria Rubra Vera
 ;;^UTILITY(U,$J,358.3,14122,1,5,0)
 ;;=5^238.4
 ;;^UTILITY(U,$J,358.3,14122,2)
 ;;=^304816
 ;;^UTILITY(U,$J,358.3,14123,0)
 ;;=238.6^^85^876^49
 ;;^UTILITY(U,$J,358.3,14123,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14123,1,4,0)
 ;;=4^Plasmacytoma NOS
 ;;^UTILITY(U,$J,358.3,14123,1,5,0)
 ;;=5^238.6
 ;;^UTILITY(U,$J,358.3,14123,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,14124,0)
 ;;=238.79^^85^876^42
 ;;^UTILITY(U,$J,358.3,14124,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14124,1,4,0)
 ;;=4^Lymph/Hematpoitc Tis NEC
 ;;^UTILITY(U,$J,358.3,14124,1,5,0)
 ;;=5^238.79
 ;;^UTILITY(U,$J,358.3,14124,2)
 ;;=^334033
 ;;^UTILITY(U,$J,358.3,14125,0)
 ;;=011.90^^85^877^74
 ;;^UTILITY(U,$J,358.3,14125,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14125,1,4,0)
 ;;=4^Tuberculosis
 ;;^UTILITY(U,$J,358.3,14125,1,5,0)
 ;;=5^011.90
 ;;^UTILITY(U,$J,358.3,14125,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,14126,0)
 ;;=031.0^^85^877^44
 ;;^UTILITY(U,$J,358.3,14126,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14126,1,4,0)
 ;;=4^Mycobacteria,Atyp,Pulmonary
 ;;^UTILITY(U,$J,358.3,14126,1,5,0)
 ;;=5^031.0
 ;;^UTILITY(U,$J,358.3,14126,2)
 ;;=^101018
 ;;^UTILITY(U,$J,358.3,14127,0)
 ;;=041.00^^85^877^67
 ;;^UTILITY(U,$J,358.3,14127,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14127,1,4,0)
 ;;=4^Streptococcus,Unspec
 ;;^UTILITY(U,$J,358.3,14127,1,5,0)
 ;;=5^041.00
 ;;^UTILITY(U,$J,358.3,14127,2)
 ;;=^293973
 ;;^UTILITY(U,$J,358.3,14128,0)
 ;;=041.01^^85^877^62
 ;;^UTILITY(U,$J,358.3,14128,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14128,1,4,0)
 ;;=4^Streptococcus,Group A
 ;;^UTILITY(U,$J,358.3,14128,1,5,0)
 ;;=5^041.01
 ;;^UTILITY(U,$J,358.3,14128,2)
 ;;=^293974
 ;;^UTILITY(U,$J,358.3,14129,0)
 ;;=041.02^^85^877^63
 ;;^UTILITY(U,$J,358.3,14129,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14129,1,4,0)
 ;;=4^Streptococcus,Group B
